Search research articles
Contact Us
Filters
Showing results (101-110 of 125) with videos related to
Page
of 13
Sort By:
Transplantation Proceedings
|
February 1, 1989
The predictive role of immunologic tests in liver transplant rejection
L C Edwards, A Nikaein, C Bryan, et al.
Leukemia & Lymphoma
|
April 28, 2000
CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells
A W Tong, B Seamour, J Chen, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
January 1, 1988
Immunochemical and structural similarities in toxin A and toxin B of Clostridium difficile shown by binding to monoclonal antibodies
S W Rothman, M K Gentry, J E Brown, et al.
Transplantation
|
October 15, 1994
HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching
A Nikaein, L Backman, L Jennings, et al.
Radiology
|
August 1, 1976
Gated blood pool imaging following 99mTc stannous pyrophosphate imaging
E M Stokely, R W Parkey, F J Bonte, et al.
Angiology
|
May 1, 1978
Myoglobinemia is an early and quantitative index of acute myocardial infarction
M J Stone, M R Waterman, L R Poliner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 1996
Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A chain-containing immunotoxins
R Baluna, E A Sausville, M J Stone, et al.
Circulation
|
February 1, 1979
Detection of myocardial infarct extension by CK-B radioimmunoassay
M Rothkopf, J Boerner, M J Stone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer
A W Tong, M H Papayoti, G Netto, et al.
Cancer Research
|
September 1, 1989
Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody
A W Tong, J Lee, R M Wang, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 125) with videos related to
Sort By:
Page
of 13
Transplantation Proceedings
|
February 1, 1989
The predictive role of immunologic tests in liver transplant rejection
L C Edwards, A Nikaein, C Bryan, et al.
Leukemia & Lymphoma
|
April 28, 2000
CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells
A W Tong, B Seamour, J Chen, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
January 1, 1988
Immunochemical and structural similarities in toxin A and toxin B of Clostridium difficile shown by binding to monoclonal antibodies
S W Rothman, M K Gentry, J E Brown, et al.
Transplantation
|
October 15, 1994
HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching
A Nikaein, L Backman, L Jennings, et al.
Radiology
|
August 1, 1976
Gated blood pool imaging following 99mTc stannous pyrophosphate imaging
E M Stokely, R W Parkey, F J Bonte, et al.
Angiology
|
May 1, 1978
Myoglobinemia is an early and quantitative index of acute myocardial infarction
M J Stone, M R Waterman, L R Poliner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 1996
Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A chain-containing immunotoxins
R Baluna, E A Sausville, M J Stone, et al.
Circulation
|
February 1, 1979
Detection of myocardial infarct extension by CK-B radioimmunoassay
M Rothkopf, J Boerner, M J Stone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer
A W Tong, M H Papayoti, G Netto, et al.
Cancer Research
|
September 1, 1989
Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody
A W Tong, J Lee, R M Wang, et al.
Page
of 13